Rob Eberschlag is a Partner at WeirFoulds LLP with a practice that is focused on corporate, commercial and securities law.
Rob has over 22 years of experience advising clients on corporate finance, mergers and acquisitions, joint ventures, divestitures, investment funds and corporate governance and compliance matters.
His number one priority is helping his clients navigate complex and ever-changing nature of securities law. Rob has a knack for taking highly technical and complex information and presenting it to his clients in a plain and easy to understand way.
He represents public companies and their financiers and has been involved in numerous stock exchange listings on the TSX, TSX Venture Exchange and the Canadian Stock Exchange through initial public offerings and reverse take-overs, including Capital Pool Company qualifying transactions. He has also been involved in the establishment of a number of natural resources investment funds. His sector experience includes transactions involving mining, life sciences, renewable energy, cleantech, oil/gas and innovation clients, including a number of significant international mandates.
XAU Resources Inc. in its closing of a Qualifying Transaction and Concurrent Financing, competed by way of a property option agreement which provides XAU Resources with an option to acquire a 100% interest in the Noseno Property. In connection with the Qualifying Transaction, XAU Resources also completed a private placement offering of subscription receipts raising gross proceeds of $1M. June 2022.
Orford Mining Corp. in its closing of a $4.4M non-brokered private placement, with each hard dollar unit consisting of one common share and one-half of a common share purchase warrant. December 2021.
StageZero Life Sciences Ltd. in the closing of a $4.2M private placement of its Common Shares and Warrants to purchase Common Shares with institutional investors. December 2021.
PNG Copper Inc. in its closing of the third and final tranche of a $1.12M private placement, with each unit consisting of one Class A common share in the capital of the Company and one Share purchase warrant. September 2021.
Orford Mining Corp. in its closing of a $1.92M non-brokered private placement of: flow-through units and hard dollar units, with flow-through units consisting of one common share and one-half of a common share purchase warrant. August 2021.
Psyence Group Inc. in its listing on the Canadian Securities Exchange; including its reverse take-over transaction with MindHealth Biomed Inc.; and MindHealth BioMed Corp.’s $9.3M non-brokered common share and subscription receipt private placements. January 2021.
StageZero Life Sciences Ltd. in its $7.2M public offering of 9,243,700 units. Each Unit was comprised of one common share and one-half of one common share purchase warrant. December 2020.
Orford Mining Corp. in its closing of a $5.25M non-brokered private placement of: flow-through units at an issue price of C$0.315 per unit, and hard dollar units at an issue price of C$0.18 per unit. October 2020.
Hemlo Explorers Inc. in its closing of a fully-subscribed $3.5M non-brokered private placement. August 2020.
Kontrol Energy Corp. in its $2.7M acquisition of New Found Air, paid as $1.55 Million in cash, $750,000 vendor take-back loan having performance conditions, and the issuance of 727,272 Kontrol common shares at a deemed price of $0.55 cents per share. August 2020.
Kontrol Energy Corp. in its $2M private placement of Units, each of which consisted of one $1,000 8% unsecured convertible debenture and 1,000 warrants. July 2020.
StageZero Life Sciences Ltd. in its $4.6M public offering. June 2020.
Antibe Therapeutics in its $28.75M bought deal public offering. June 2020.
Canadian Orebodies Inc., a junior natural resource exploration and development company with a number of mineral properties located in Canada, in its acquisition of Hemlo Area Properties from O3 Mining Inc. May 2020.
Kontrol Energy Corp., developer of smart energy solutions and technologies, in the $3.4-million acquisition of CEM Specialities Inc., a leading integrator of turn-key emission monitoring equipment and solutions. October 2019.
Antibe Therapeutics Inc. in a $5.75-million bought deal public offering of 23,000,000 units of the Company at a price of $0.25 per Unit. February 2019.
Pelangio Exploration in a non-brokered $750,000 private placement. January 2019.
Pelangio Exploration in its acquisition of 2522962 Ontario Inc. (5SD Capital), a private company engaged in the trading and exploring of Canadian mineral properties. December 2018.
Pelangio Exploration in a non-brokered $1,200,000 private placement of units. January 2018.
- Recognized in Best Lawyers in Canada as a leading practitioner in Mining Law, 2023
- Repeatedly recognized in the Canadian Legal Lexpert Directory as a leading practitioner in Mining
- Peer ranked “AV Preeminent” by Martindale-Hubbell Peer Review (Martindale’s highest ranking)
Called to the Bar
- Ontario, 2000
- University of Victoria LL.B. 1998
- Dalhousie University M.A 1994
- Queen's University B.A. 1993 Hons.
In the News
- Lexis Practice Advisor Canada module on joint ventures (co-author)
- “Financing and Other Exploration, Development and Production Considerations” (co-author), chapter in American Law of Mining, 2nd ed., The Rocky Mountain Mineral Law Foundation, LexisNexis Matthew Bender
- “New Prospectus Exemptions for Issuers” (co-author), CIM Bulletin, November 2005
- “Culture Clash: Canadian Periodical Policies and the WTO,” Manitoba Law Journal, 26, p. 65-96, 1999